PPARδ-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 2, 2009, Pages

  Sue, Yuh Mou ^a   Chung, Chih Peng ^a   Lin, Heng ^b   Chou, Ying ^a   Jen, Chih Yu ^a   Li, Hsiao Fen ^c   Chang, Chih Cheng ^a   Juan, Shu Hui ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Antiproliferation; cAMP responsive element; cAMP responsive element binding protein; cAMP responsive element binding protein binding protein

Indexed keywords

BERAPROST; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROTEIN P21; PROTEIN P27; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DRUG DERIVATIVE; PROSTACYCLIN; SMALL INTERFERING RNA; VASODILATOR AGENT;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; ACTIVE TRANSPORT; ANIMAL; AORTA; CYTOLOGY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

MURINAE; MUS; RATTUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; AORTA; CELL PROLIFERATION; CREB-BINDING PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPOPROSTENOL; HUMANS; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PPAR DELTA; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; VASODILATOR AGENTS;

EID: 68849103137     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00069.2009     Document Type: Article

References (35)

1. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med 10: 355-361, 2004.
2. Fisher-Dzoga K, Jones RM, Vesselinovitch D, Wissler RW. Ultrastructural and immunohistochemical studies of primary cultures of aortic medial cells. Exp Mol Pathol 18: 162-176, 1973.
3. Geiger TR, Sharma N, Kim YM, Nyborg JK. The human T-cell leukemia virus type 1 tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB. Mol Cell Biol 28: 1383-1392, 2008.
4. Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Develop 14: 1553-1577, 2000.
5. Graham TL, Mookherjee C, Suckling KE, Palmer CN, Patel L. The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice. Atherosclerosis 181: 29-37, 2005.
6. Grossman SR. p300/CBP/p53 interaction and regulation of the p53 response. Eur J Biochem 268: 2773-2778, 2001.
7. Hertz R, Berman I, Keppler D, and Bar-Tana J. Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome- proliferators-activated receptor (PPAR). Eur J Biochem 235: 242-247, 1996.
8. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344: 1608-1621, 2001.
9. Ii M, Hoshiga M, Fukui R, Negoro N, Nakakoji T, Nishiguchi F, Kohbayashi E, Ishihara T, Hanafusa T. Beraprost sodium regulates cell cycle in vascular smooth muscle cells through cAMP signaling by preventing down-regulation of p27(Kip1). Cardiovasc Res 52: 500-508, 2001.
10. Jain M, He Q, Lee WS, Kashiki S, Foster LC, Tsai JC, Lee ME, Haber E. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest 97: 596-603, 1996.
11. Kang-Decker N, Tong C, Boussouar F, Baker DJ, Xu W, Leontovich AA, Taylor WR, Brindle PK, van Deursen JM. Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. Cancer Cell 5: 177-189, 2004.
12. Kim DJ, Murray IA, Burns AM, Gonzalez FJ, Perdew GH, Peters JM. Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem 280: 9519-9527, 2005.
13. Lin H, Lee JL, Hou HH, Chung CP, Hsu SP, Juan SH. Molecular mechanisms of the antiproliferative effect of beraprost, a prostacyclin agonist, in murine vascular smooth muscle cells. J Cell Physiol 214: 434-441, 2008.
14. Lin Y, Zhu X, McLntee FL, Xiao H, Zhang J, Fu M, Chen YE. Interferon regulatory factor-1 mediates PPARgamma-induced apoptosis in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 257-263, 2004.
15. Mochizuki K, Suruga K, Sakaguchi N, Takase S, Goda T. Major intestinal coactivator p300 strongly activates peroxisome proliferatoractivated receptor in intestinal cell line, Caco-2. Gene 291: 271-277, 2002.
16. Nakajima T, Uchida C, Anderson SF, Lee CG, Hurwitz J, Parvin JD, Montminy M. RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90: 1107-1112, 1997.
17. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, functions. Physiol Rev 79: 1193-1226, 1999.
18. Niwano K, Arai M, Tomaru K, Uchiyama T, Ohyama Y, Kurabayashi M. Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways. Circ Res 93: 523-530, 2003.
19. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959, 1996.
20. Ohtsubo H, Ichiki T, Miyazaki R, Inanaga K, Imayama I, Hashiguchi Y, Sadoshima J, Sunagawa K. Inducible cAMP early repressor inhibits growth of vascular smooth muscle cell. Arterioscler Thromb Vasc Biol 27: 1549-1555, 2007.
21. Pang PH, Lin YH, Lee YH, Hou HH, Hsu SP, Juan SH. Molecular mechanisms of p21 and p27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells. J Cell Physiol 215: 161-171, 2008.
22. Piech-Dumas KM, Best JA, Chen Y, Nagamoto-Combs K, Osterhout CA, Tank AW. The cAMP responsive element and CREB partially mediate the response of the tyrosine hydroxylase gene to phorbol ester. J Neurochem 76: 1376-1385, 2001.
23. Prescott SM, White RL. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 87: 783-786, 1996.
24. Sato J, Nair K, Hiddinga J, Eberhardt NL, Fitzpatrick LA, Katusic ZS, O'Brien T. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res 47: 697-706, 2000.
25. Shearer BG, Steger DJ, Way JM, Stanley TB, Lobe DC, Grillot DA, Iannone MA, Lazar MA, Willson TM, Billin AN. Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol Endocrinol 22: 523-529, 2008.
26. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Develop 13: 1501-1512, 1999.
27. Vane JR, Botting RM. Pharmacodynamic profile of prostacyclin. Am J Cardiol 75: 3A-10A, 1995.
28. Weber AA, Zucker TP, Hasse A, Bonisch D, Wittpoth M, Schror K. Antimitogenic effects of vasodilatory prostaglandins in coronary artery smooth muscle cells. Basic Res Cardiol 93, Suppl 3: 54-57, 1998.
29. Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, Wang DL. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 81: 1-7, 1997.
30. Xu W, Kasper LH, Lerach S, Jeevan T, Brindle PK. Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. EMBO J 26: 2890-2903, 2007.
31. Yokoyama U, Minamisawa S, Quan H, Akaike T, Jin M, Otsu K, Ulucan C, Wang X, Baljinnyam E, Takaoka M, Sata M, Ishikawa Y. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am J Physiol Heart Circ Physiol 295: H1547-H1555, 2008.
32. Zeng Q, Ran PX, Chen SC, Liu JS. The inhibitory mechanism of nitri-oxide synthase gene transfection on hypoxia-induced proliferation of rat pulmonary arterial smooth muscle cells. Zhonghua Jie He He Hu Xi Za Zhi 26: 358-361, 2003.
33. Zhang J, Fu M, Zhu X, Xiao Y, Mou Y, Zheng H, Akinbami MA, Wang Q, Chen YE. Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes postconfluent cell proliferation in vascular smooth muscle cells. J Biol Chem 277: 11505-11512, 2002.
34. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen E, Kadam S, Ecker JR, Emerson B, Hogenesch JB, Unterman T, Young RA, Montminy M. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 102: 4459-4464, 2005.
35. Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM, Lippman SM, Shureiqi I. Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene 25: 1225-1241, 2006.